We have prepared monoclonal antibodies to the capsid protein of feline calicivirus (FCV). These antibodies are directed against two close but distinct epitopes, only one of which is involved in virus neutralization, We have used these antibodies and immune cat serum in immunoprecipitation and Western blotting experiments and have identified novel proteins in FCV-infected cells which we term P78, P41, P35 and P29. The number and sizes of FCV proteins now known resemble those made by other caliciviruses.
Lysates were prepared and processed for immunoprecipitation as previously described using aprotinin and PMSF to inhibit proteolytic cleavage (Baczko et al., 1984) . Proteins were analysed by electrophoresis through a 10~ polyacrylamide gel and detected by fluorography. Infected cell extracts (lanes 1, 3, 5 and 7) and mockinfected cell extracts (lanes 2, 4, 6 and 8) were treated with monoclonal antibodies 1G9 (lanes 1 and 2) and 1 El (lanes 3 and 4) or with polyclonal serum from an immunized cat (lanes 5 and 6) or no antibody (lanes 7 and 8). or 24 (lane 1) h post-infection and processed for electrophoresis. Mock-infected ceils were treated in a similar manner. Proteins were then separated on a 10 ~ polyacrylamide gel, transferred to nitrocellulose filters and detected using monoclonal antibodies as described . It seemed appropriate to produce monoclonal antibodies in order to examine the relationships between the polypeptides. Such antibodies would also be of use in the investigation of strain variation and analysis of protein structure and function. Monoclonal antibodies were therefore produced by the following method. Twelve mice were bled from the orbital sinus before immunization and the blood was stored for later assay. Mice were inoculated in the footpad on day 1 of the procedure using 25 ~tl of C R F K cell antigen emulsified in Freund's complete adjuvant. Four of the mice received uninfected cell antigens and the other eight received infected cell antigen harvested 24 h post-infection. The stimulus was repeated on day 7 postinoculation when each mouse received 50 ~tl of antigen without adjuvant intraperitoneally and 50 p.1 intravenously. The final inoculation was made on day 20 and consisted of 25 ~tl of antigen without adjuvant intravenously, 25 Ixl of antigen in adjuvant per footpad, and 100 ~tl subcutaneously to the neck. The mice were bled again on day 27 and tested for the development of antibodies in an ELISA. All mice immunized showed an increased reactivity to uninfected cell antigens, but those which had received the infected cell lysates discriminated well between infected and non-infected cell antigens.
The protocol for the production of monoclonal antibodies was the same as that employed to produce such antibodies specific for respiratory syncytial virus, and has already been reported (Routledge et al., 1985) . In brief, spleens were removed from selected animals and lymphocytes were fused with NS1 myeloma cells using polyethylene glycol. Fused cells were selected in H A T medium and the media from any hybridoma cells that grew were tested by ELISA for the presence of antibodies specific for FCV. Positive cells were cloned by dilution in the presence of . ELISA titration of monoclonal antibodies, both separately and in combination, as described (Routledge et al., 1985) . Antibodies used were obtained from hybridoma cell tissue culture media and titrated using FCV-infected CRFK cell antigen. (O) 1G9 alone; (A) 1El alone; (ll) IG9 plus 1El.
spleen feeder cells and re-tested for antibody secretion. In this way two hybridoma cell lines, 1G9 and 1El, were obtained which secreted high levels of FCV-specific antibody. Each was inoculated into the peritoneal cavities of pristane-primed mice from which ascites fluid could be recovered. The monoclonal antibodies described above were tested in immunoprecipitations and both were found to react with the capsid protein (Fig. 1) . Both also recognized this protein in Western blots (Fig. 2) . The abilities of these antibodies to neutralize FCV were therefore examined in a plaque reduction assay using CRFK ceils. Although both antibodies were present at high titre in ELISAs, 1 G9 was found to have an excellent neutralizing capability whereas neutralization by I E 1 could not be detected. Consequently it can be concluded that there are at least two distinct epitopes on this protein, only one of which is associated with virus neutralization. Further evidence for the physical separation of these epitopes was provided by Western blot experiments in which infected cells were harvested after the completion of the virus replication cycle. These cells contained a 40K peptide which was recognized well by antibody 1G9, but not by 1E 1 (Fig.  2, lanes 1) . This band was also detected in immunoprecipitation experiments conducted in the absence of protease inhibitors (data not shown), and is thus most likely to result from proteolysis of the capsid protein.
The relative positions of the two epitopes were then examined by testing the antibodies for additive binding. This test, developed by Routledge et al. (1986) , examines the effect of allowing the antibodies to bind to the antigen under conditions in which at least one of them is saturating. Provided sufficient of the second antibody is added, a significant increase in absorbance should be detected by an ELISA. In order to ensure that these conditions were met, this test was performed by testing the two antibodies, both separately and in combination, in an ELISA (Fig.  3) . In this way the absorbance values expected from the binding of the individual antibodies could be determined and compared with the value obtained from the mixture at each dilution. However, there were no differences in the total amount of antibody that could be bound when the antigen was saturated (Fig. 3) . The two epitopes concerned therefore appear to be sufficiently close together for binding of one antibody effectively to exclude the other.
Calicivirus proteins almost certainly mature by a process of proteolytic cleavage, and an 86K precursor to mature capsid protein has been identified in SMSV-infected cells using procedures which inhibit protein processing (Fretz & Schaffer, 1978) . Since the monoclonal antibodies described here react with epitopes which are stable to the denaturing effects of SDSpolyacrylamide gel electrophoresis, they should also detect any precursors to the capsid protein, but we have not observed these in infected cells. This indicates that any modifications must closely follow peptide synthesis. Experiments are in progress to elucidate this process more fully.
